Riboflavin 5 Phosphate Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 6 USDMF, 2 CEP/COS, 5 JDMF, 4 EU WC, 7 NDC API, 6 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 13 FDA Orange Book, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 6 DKSH, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 4 BASF, 1 Bioplus Life Sciences, 2 Finar, 6 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 8 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

24 Fillers, Diluents & Binders, 19 Parenteral, 17 Solubilizers, 15 Taste Masking, 14 Film Formers & Plasticizers, 11 Topical, 11 Chewable & Orodispersible Aids, 10 Direct Compression, 9 Thickeners and Stabilizers, 8 Empty Capsules, 8 Coating Systems & Additives, 5 Emulsifying Agents, 5 Co-Processed Excipients, 4 Surfactant & Foaming Agents, 3 Disintegrants & Superdisintegrants, 3 Granulation, 2 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Controlled & Modified Release

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

MARKET PLACE

9 APIs, 1 EXCIPIENTS

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21625 / DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

Inactive Ingredients

Ingredient Name	Hospira, Inc.
BUTYLATED HYDROXYANISOLE(REK4960K2U)
BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
GENTISIC ACID ETHANOLAMIDE(H4E039OIGX)
POLYSORBATE 20(7T1F30V5YH)
POLYSORBATE 80(6OZP39ZG8H)
PROPYLENE GLYCOL(6DC9Q167V3)
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)
SODIUM HYDROXIDE(55X04QC32I)

Drug Product Composition: Riboflavin 5 Phosphate Sodium